Booth, S., Curley, H. M., Varnai, C., Arnold, R., Lee, L. Y. W., Campton, N. A., Cook, G., Purshouse, K., Aries, J., Innes, A., Cook, L. B., Tomkins, O., Oram, H. S., Tilby, M., Kulasekararaj, A., Wrench, D., Dolly, S., Newsom‐Davies, T., Pettengell, R., Gault, A., Moody, S., Mittal, S., Altohami, M., Tillet, T., Illingworth, J., Mukherjee, L., Apperly, J., Ashcroft, J., Rabin, N., Carmichael, J., Cazier, J., Kerr, R., Middleton, G., Collins, G. P., Palles, C., & , (2022). key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy. British journal of haematology, 196, 892–901. http://access.bl.uk/ark:/81055/vdc_100180567901.0x00005d